Interactive Investor
>>

Cyclo Therapeutics Inc (NASDAQ:CYTH) Share Price

CYTH

Cyclo Therapeutics Inc

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Drug Manufacturers - Specialty & Generic

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.CTD Holdings Inc is engaged in marketing and sale of cyclodextrins and related products to food, pharmaceutical and other industries for use in diagnostics and specialty drugs with continuing growth in research and new product development.

NASDAQ:CYTH

US23254X2018

USD

Loading...

Loading Comparison

Latest CYTH News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News